ECO Animal Health Group plc (EAH.L) LSE
Currency In GBp
- General
- Statistics
- Historical Data
- Profile
- Financials
ECO Animal Health Group plc
Address
The Grange
London, LO N14 6BN
United Kingdom of Great Britain and Northern Ireland (the)
Phone
44 20 8336 2900
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
213
First IPO Date
September 26, 1995
Key Executives
| Name | Title | Pay | Year Born |
| David Charles Hallas | Chief Executive Officer & Director | 637,000 | 1964 |
| Christopher Wilks | Chief Financial Officer, Finance Director, Secretary & Director | 522,000 | 1964 |
| Andrew Winder | Head of Business Development | 0 | N/A |
| Andrew Buglass | Chief Commercial Officer | 0 | N/A |
Description
ECO Animal Health Group plc, established in 1972 and based in New Malden, United Kingdom, focuses on the worldwide research, regulatory approval, and distribution of veterinary pharmaceutical solutions. The company's offerings include Aivlosin, a macrolide antibiotic specifically formulated to address digestive and respiratory illnesses in pigs and poultry. Additionally, its product range encompasses various generic drugs like Ecomectin, Ecoheart, Ecotraz, and Ecomintic. These endectocides and other antiparasitics are designed to manage and prevent parasitic infestations such as worms, ticks, and lice across a diverse array of animals, including cattle, sheep, pigs, horses, and dogs. ECO Animal Health Group also provides Chlortetracycline and Oxytetracycline for treating bacterial infections in swine, fowl, and bovine animals.
